C+A Global Launches New HP Touch Screen Film Scanner

Building Upon the Brand's Robust Lineup of Photo Gadgets, the Film Scanner Offers a New Way to Capture Old Memories C+A Global, an authorized brand licensee of HP, today announced the official launch of the HP FilmScan 5″ Touch Screen Film Scanner, a unique film scanner that allows users to scan negatives and slides to […]

CHO Plus Obtains U.S. Patent for Improved Production of Proteins Using Engineered Yeast Cells

CHO Plus Obtains U.S. Patent for Improved Production of Proteins Using Engineered Yeast Cells Cell Engineering Technology Will Increase Recombinant Protein Production for Food Ingredients, Industrial Enzymes, and Other Products GlobeNewswire September 09, 2025 SOUTH SAN FRANCISCO, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) — CHO Plus, Inc. (www.CHO-Plus.com), a leading developer of biopharmaceutical manufacturing technology,

Aembit Named to Fast Company’s Seventh-Annual List of the 100 Best Workplaces for Innovators

SILVER SPRING, Md., Sept. 09, 2025 (GLOBE NEWSWIRE) — Fast Company today announced its seventh-annual Best Workplaces for Innovators list, recognizing businesses that foster a culture of innovation across all levels. Aembit, the non-human IAM company, earned the No. 43 spot for its breakthroughs in securing workload identities and its pioneering work at the intersection

DEADLINE APPROACHING: Berger Montague Advises Sable Offshore Corp. (NYSE: SOC) Investors to Inquire About a Securities Fraud Class Action by September 26, 2025

National plaintiffs' law firm Berger Montague PCannounces a class action lawsuit againstSable Offshore Corp.(NYSE: SOC) (“Sable” or the “Company”) on behalf of investors who purchased or otherwise acquired publicly traded securities of Sable betweenMay 19, 2025 through June 3, 2025 (the “Class Period”), including on or traceable to the Company's May 2025 secondary public offering.

Aembit Named to Fast Company’s Seventh-Annual List of the 100 Best Workplaces for Innovators

Aembit Named to Fast Company's Seventh-Annual List of the 100 Best Workplaces for Innovators GlobeNewswire September 09, 2025 SILVER SPRING, Md., Sept. 09, 2025 (GLOBE NEWSWIRE) — Fast Company today announced its seventh-annual Best Workplaces for Innovators list, recognizing businesses that foster a culture of innovation across all levels. Aembit, the non-human IAM company, earned

Cuprina Secures Exclusive Rights to Southeast Asia’s First UNIDO/GEF- Demonstrated Medical Waste Recycling Technology

(NASDAQ:CUPR), SINGAPORE, Sept. 09, 2025 (GLOBE NEWSWIRE) — Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company“), a biomedical and biotechnology company dedicated to the development and commercialization of products for the management of chronic wounds and infertility, as well as cosmeceuticals for the health and beauty sector, today announced it has secured exclusive

24/7 Market News: Ken Le, Not Stan Lee, to Lead Prodigy Silk’s Super Fiber Deliveries to Global Brands for Kraig Labs

(Other OTC:KBLB),(OTC US:KBLB), DENVER, Sept. 09, 2025 (GLOBE NEWSWIRE) — 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and information, analyses Kraig Biocraft Laboratories (OTCQB: KBLB), the undisputed global leader in the development and commercialization of spider silk, appointment of Kenneth Le as Managing Director of Prodigy Silk

NKGen Biotech, Inc. Announces Completion of NKMax Co., Ltd. Acquisition; Gains Full Control of Global Manufacturing and Intellectual Property Assets

(PinkSheets:NKGN),(Pinksheets:NKGN), NKGen acquires controlling stake in NKMax, marking a pivotal moment in its transformation into a fully integrated, self-sustaining, cell therapy company with global manufacturing and IP control. Approximately $16.9 million paid to acquire 65% equity stake in recapitalized debt-free NKMax, with NKMax operations now expected to be funded through 2026. Funding provided by AlpineBrook

Cellectar Biosciences to Participate at Oppenheimer 3rd Annual Targeted Radiopharmaceutical Therapies in Oncology Summit

(NASDAQ:CLRB),(NASDAQ:CLRBW),(NASDAQ:CLRBZ), Highlighting Continued Progress with EMA Regarding a Potential Conditional Marketing Authorization Submission for Iopofosine I 131 to Treat Waldenstrom Macroglobulinemia (WM) in the EU; Decision on Track for Late 3Q25/Early 4Q25 Intention to Pursue an Accelerated Approval with the U.S. Food and Drug Administration for Iopofosine I 131 as a Treatment for WM Advancing

24/7 Market News TEN Holdings Supercharges Growth with SaaS and Synergies

(NASDAQ:XHLD), DENVER, Sept. 09, 2025 (GLOBE NEWSWIRE) — 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, reports that TEN Holdings (NASDAQ: XHLD), a provider of event planning, production, and broadcasting services through its operating subsidiary Ten Events, is demonstrating robust execution and accelerating growth, according

Scroll to Top